Systems & policy research
for the bone health field.
A working paper series examining the structural forces shaping bone health investment, care delivery, and field infrastructure. Written for payers, investors, health system leaders, and clinicians who shape what happens next.
Working Papers
Structural analysis
for field decision-makers.
Written for health system executives, payers, investors, and clinicians who need to understand what is actually constraining the bone health field — and where capital, policy, and infrastructure need to move.
The Unintended Dividend
How SABRE Could Restructure the Operational Landscape of Bone Health
A December 2025 FDA regulatory decision designed to accelerate osteoporosis drug development may have created — as an unintended consequence — the conditions under which the field could finally build the patient discovery infrastructure it has always needed but never had sufficient urgency to fund.
Osteoporosis
Receive No Treatment
Osteoporosis Drug Was Approved
Revised & Expanded · March 2026
Unlocking Refrigerated Capital
A Structural Investment Reset for Bone Health
A meaningful portion of the capital needed to scale bone health infrastructure already exists within the system. It is not missing. It is immobilized — locked inside drug inventory held in clinic refrigerators across thousands of independent community practices nationwide.
Frozen in Refrigerators
Osteoporosis Market
Receive No Treatment
Companion Paper to Intelligence Series No. 001
A New Category Is Forming
The Rise of Independent Midlife Women's Health Clinics
An emerging clinic category is quietly redefining how bone health care reaches women in the decade before peak fracture risk — outside the traditional specialty referral pathway.
Releasing in the Intelligence Series — subscribe for updates